Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels

Fig. 5

Comparison of s-ING1-Ab levels among stages of CRC. Serum antibody levels against the bING1-239 peptide were compared among pathological properties including A pathological stages, B lymphatic invasion (ly), and C venous invasion (v) in 133 patients with CRC. Patients treated with chemotherapy and/or palliative colostomy only or with neo adjuvant therapy were excluded. The sample number of each stage and invasion status are shown in Additional file 1: Table S4. Comparisons were made using Dunn’s multiple comparison test following a Kruscal-Wallis test (p < 0.001). (A), and the Mann–Whitney U test (B, C)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us